3D printed chitosan/polycaprolactone scaffold for lung tissue engineering: hope to be useful for COVID-19 studies

3D-печатный каркас из хитозана/поликапролактона для тканевой инженерии легких: потенциальное применение в исследованиях COVID-19
Javad Esmaeili, Aboulfazl Barati, Farzaneh Mahmoudi Beram, Farnoush Sadat Rezaei, Ayeh Khorshidian, Atefeh Derakhshani
2021-01-01

3D-printed scaffoldCOVID-19 studiesMRC-5 cell culturechitosan/polycaprolactonelung tissue engineering
. To sum up, scaffold 3 (chitosan/polycaprolactone ratio: 4 : 1) revealed better activity for MRC-5 cell culture. Thereby, this scaffold can be a good candidate for lung tissue engineering and may be applicable for more studies on the COVID-19 virus.
1
Among the tested formulations, scaffold 3 with a chitosan/polycaprolactone ratio of 4:1 showed the best activity in MRC-5 cell culture.
2
The 4:1 chitosan/polycaprolactone scaffold is identified as a potential candidate for lung tissue engineering.
3
The scaffold may support future studies involving COVID-19, although the abstract does not report direct antiviral or infection-related testing.

3D-printed chitosan/polycaprolactone scaffold for lung tissue engineering

MRC-5 cell-culture activity of the chitosan/polycaprolactone scaffold, including its suitability as a lung-tissue-engineering candidate

Publication Details
Publication Date
2021-01-01
Journal
Publisher
ISSN
Cited by
61
Access Type
Author Information
Authors
Javad Esmaeili
Aboulfazl Barati
Farzaneh Mahmoudi Beram
Farnoush Sadat Rezaei
Ayeh Khorshidian
Atefeh Derakhshani
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%